
Johnson & Johnson favored over Pfizer for steady growth and dividend in 2027 healthcare sector race
Johnson & Johnson and Pfizer are key healthcare giants with differing strategies: J&J balances drug innovation and medical devices, while Pfizer focuses on oncology and obesity treatments. J&J reported stronger revenue growth and higher net income, w...





